APIXABAN

Clinical Indication

Prevention of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation

Comments

Use in line with
DOAC Initiation Pack

Date of classification

April 2015

Green

Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.